Merit Medical Systems (NASDAQ:MMSI) and Stryker (NYSE:SYK) Critical Comparison

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) and Stryker (NYSE:SYK – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation.

Institutional & Insider Ownership

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by insiders. Comparatively, 4.6% of Stryker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Merit Medical Systems and Stryker, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems 0 5 8 0 2.62
Stryker 0 7 21 0 2.75

Merit Medical Systems presently has a consensus price target of $105.91, suggesting a potential upside of 25.47%. Stryker has a consensus price target of $343.77, suggesting a potential upside of 9.77%. Given Merit Medical Systems’ higher possible upside, equities research analysts clearly believe Merit Medical Systems is more favorable than Stryker.

Risk & Volatility

Merit Medical Systems has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Earnings & Valuation

This table compares Merit Medical Systems and Stryker”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Merit Medical Systems $1.61 billion 3.14 $128.49 million $2.66 31.73
Stryker $25.12 billion 4.75 $3.25 billion $9.39 33.35

Stryker has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Merit Medical Systems and Stryker’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Merit Medical Systems 9.94% 14.12% 8.37%
Stryker 13.78% 23.74% 11.64%

Summary

Stryker beats Merit Medical Systems on 12 of the 14 factors compared between the two stocks.

About Merit Medical Systems

(Get Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

About Stryker

(Get Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.